Amazon Pharmacy will now deliver prescription medications for diabetes, obesity and migraines directly to patients' doors.
Four months after Eli Lilly obtained regulatory approval to sell its diabetes medication under a different name for weight loss, the pharmaceutical giant is teaming up with Amazon to deliver the drug and other medications directly to people's door.The drugmaker's tirzepatide medication, branded as Mounjaro for diabetes, is now being marketed as Zepbound for weight loss and is administered with an injection pen.
Only certain drugs can be ordered through Lilly's platform, which uses third-party online pharmacies to fill and ship prescriptions. The process in many cases eliminates the need to physically see a doctor to obtain a prescription and, in certain cases, trekking to a pharmacy to fill it. The partnership with Amazon comes amid surging demand for Zepbound and other weight-loss drugs, some of which have seen intermittent shortages during the last year.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients Amazon Pharmacy second online pharmacy to partner with Eli Lilly’s site, and could provide faster deliveries for certain patients.
Lire la suite »
10 things to watch in the stock market, including Eli Lilly, Amazon, Meta and FordU.S. stocks are little changed early Wednesday, one day after a strong rally sent to the S&P 500 to a new record close.
Lire la suite »
Amazon Pharmacy Partners with Eli Lilly to Deliver Medications to Customers' HomesAmazon Pharmacy will serve as a third-party dispensing provider for LillyDirect, allowing patients to receive direct home delivery of select Lilly medicines. With Amazon's logistics and supply chain management, customers will have access to ongoing tracking updates and customer care teams.
Lire la suite »
Eli Lilly's Alzheimer's drug delayed by FDA: ‘It was unexpected’On Friday, the FDA announced it would postpone a decision on Eli Lilly's potential Alzheimer's treatment donanemab.
Lire la suite »
Eli Lilly's new ad says weight-loss drugs shouldn't be used out of 'vanity'In a new ad that nods to the 2024 Oscars, the pharmaceutical firm discourages people from using drugs like Mounjaro for cosmetic weight loss.
Lire la suite »
Eli Lilly says Alzheimer’s drug approval delayed as FDA seeks input from advisersDrugmaker Eli Lilly says that approval of its experimental Alzheimer’s medication donanemab will be delayed beyond the end of March as the FDA plans to call a last-minute meeting of its advisers
Lire la suite »